Impact of cyclin-dependent kinase CDK4 inhibition on eryptosis

Cellular Physiology and Biochemistry

Volumn 37, Issue 3, 2015, Pages 1178-1186

  Lang, Elisabeth ^a,b   Zelenak, Christine ^c   Eberhard, Matthias ^a   Bissinger, Rosi ^a   Rotte, Anand ^d   Ghashghaeinia, Mehrdad ^a   Lupescu, Adrian ^a   Lang, Florian ^a   Qadri, Syed M ^e  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Apoptosis; Calcium; CDK4; Cell shrinkage; Eryptosis

Indexed keywords

CYCLIN DEPENDENT KINASE 4; LIPOCORTIN 5; CDK4 PROTEIN, HUMAN; PHOSPHATIDYLSERINE; PROTEIN KINASE INHIBITOR; TERT BUTYL HYDROPEROXIDE;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ERYPTOSIS; ERYTHROCYTE MEMBRANE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; K562 CELL LINE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; ERYTHROCYTE; METABOLISM;

APOPTOSIS; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 4; ERYTHROCYTES; HUMANS; PHOSPHATIDYLSERINES; PROTEIN KINASE INHIBITORS; TERT-BUTYLHYDROPEROXIDE;

EID: 84945895419     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430241     Document Type: Article

References (54)

1. Shapiro GI: Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 2006; 24:1770-1783.
2. Aggarwal BB, Ichikawa H: Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 2005; 4:1201-1215.
3. Ibrahim N, Haluska FG: Molecular pathogenesis of cutaneous melanocytic neoplasms. Annu Rev Pathol 2009; 4:551-579.
4. Nelson AA, Tsao H: Melanoma and genetics. Clin Dermatol 2009; 27:46-52.
5. Choi YJ, Anders L: Signaling through cyclin D-dependent kinases. Oncogene 2014; 33:1890-1903.
6. Han YK, Lee JH, Park G.Y., Chun SH, Han JY, Kim SD, Lee J, Lee C.W., Yang K., Lee CG: A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy. Biochem Biophys Res Commun 2013; 430:1329-1333.
7. Lee W, Kim KY, Yu S.N., Kim SH, Chun SS, Ji JH, Yu H.S., Ahn SC: Pipernonaline from Piper longum Linn. induces ROS-mediated apoptosis in human prostate cancer PC-3 cells. Biochem Biophys Res Commun 2013; 430:406-412.
8. Wu Q, Kang Y, Zhang H., Wang H, Liu Y, Wang J: The anticancer effects of hispolon on lung cancer cells. Biochem Biophys Res Commun 2014; 453:385-391.
9. Sheppard KE, McArthur GA: The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma. Clin Cancer Res 2013; 19:5320-5328.
10. Greene LA, Liu DX, Troy C.M., Biswas SC: Cell cycle molecules define a pathway required for neuron death in development and disease. Biochim Biophys Acta 2007; 1772:392-401.
11. Alexandrou AT, Li JJ: Cell cycle regulators guide mitochondrial activity in radiation-induced adaptive response. Antioxid Redox Signal 2014; 20:1463-1480.
12. Lang E, Qadri SM, Lang F: Killing me softly - suicidal erythrocyte death. Int J Biochem Cell Biol 2012; 44:1236-1243.
13. Lang F, Qadri SM: Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif 2012; 33:125-130.
14. Anderson DR, Davis JL, Carraway KL: Calcium-promoted changes of the human erythrocyte membrane. Involvement of spectrin, transglutaminase, and a membrane-bound protease. J Biol Chem 1977; 252:6617-6623.
15. Allan D, Billah MM, Finean J.B., Michell RH: Release of diacylglycerol-enriched vesicles from erythrocytes with increased intracellular (Ca2+). Nature 1976; 261:58-60.
16. Cohen CM, Gascard P: Regulation and post-translational modification of erythrocyte membrane and membrane-skeletal proteins. Semin Hematol 1992; 29:244-292.
17. Minetti G, Piccinini G, Balduini C., Seppi C, Brovelli A: Tyrosine phosphorylation of band 3 protein in Ca2+/A23187-treated human erythrocytes. Biochem J 1996; 320:445-450.
18. Jayapal SR, Wang CQ, Bisteau X, Caldez M.J., Lim S., Tergaonkar V, Osato M, Kaldis P: Hematopoiesis specific loss of Cdk2 and Cdk4 results in increased erythrocyte size and delayed platelet recovery following stress. Haematologica 2015; 100:431-438.
19. Kubo A, Nakagawa K, Varma R.K., Conrad NK, Cheng JQ, Lee WC, Testa J.R., Johnson BE, Kaye FJ, Kelley MJ: The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4. Clin Cancer Res 1999; 5:4279-4286.
20. Ryu CK, Kang HY, Lee S.K., Nam KA, Hong CY, Ko WG, Lee BH: 5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents. Bioorg Med Chem Lett 2000; 10:461-464.
21. Foller M, Sopjani M, Koka S., Gu S, Mahmud H, Wang K., Floride E, Schleicher E, Schulz E., Munzel T, Lang F: Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009; 23:1072-1080.
22. Zelenak C, Eberhard M, Jilani K., Qadri SM, Macek B, Lang F: Protein kinase CK1alpha regulates erythrocyte survival. Cell Physiol Biochem 2012; 29:171-180.
23. Bhavsar SK, Gu S, Bobbala D., Lang F: Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 2011; 27:547-556.
24. Gatidis S, Zelenak C, Fajol A., Lang E, Jilani K, Michael D., Qadri SM, Lang F: p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011; 28:1279-1286.
25. Zelenak C, Foller M, Velic A., Krug K, Qadri SM, Viollet B, Lang F., Macek B: Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis. J Proteome Res 2011; 10:1690-1697.
26. Lang E, Lang F: Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death. Biomed Res Int 2015; 2015:513518.
27. Lang F, Abed M, Lang E., Foller M: Oxidative stress and suicidal erythrocyte death. Antioxid Redox Signal 2014; 21:138-153.
28. Zidova Z, Kapralova K, Koralkova P., Mojzikova R, Dolezal D, Divoky V., Horvathova M: DMT1-mutant erythrocytes have shortened life span, accelerated glycolysis and increased oxidative stress. Cell Physiol Biochem 2014; 34:2221-2231.
29. Burhans WC, Heintz NH: The cell cycle is a redox cycle: linking phase-specific targets to cell fate. Free Radic Biol Med 2009; 47:1282-1293.
30. Menon SG, Goswami PC: A redox cycle within the cell cycle: ring in the old with the new. Oncogene 2007; 26:1101-1109.
31. Martin EA, Robinson PJ, Franklin RA: Oxidative stress regulates the interaction of p16 with Cdk4. Biochem Biophys Res Commun 2000; 275:764-767.
32. Lang PA, Kempe DS, Myssina S, Tanneur V., Birka C, Laufer S, Lang F., Wieder T, Huber SM: PGE(2) in the regulation of programmed erythrocyte death. Cell Death Differ 2005; 12:415-428.
33. Matarrese P, Straface E, Pietraforte D., Gambardella L, Vona R, Maccaglia A., Minetti M, Malorni W: Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases. FASEB J 2005; 19:416-418.
34. Ghashghaeinia M, Cluitmans JC, Akel A, Dreischer P., Toulany M, Koberle M, Skabytska Y., Saki M, Biedermann T, Duszenko M., Lang F, Wieder T, Bosman GJ: The impact of erythrocyte age on eryptosis. Br J Haematol 2012; 157:606-614.
35. Ahmed MS, Langer H, Abed M., Voelkl J, Lang F: The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 2013; 37:158-167.
36. Alzoubi K, Calabro S, Bissinger R., Abed M, Faggio C, Lang F: Stimulation of suicidal erythrocyte death by artesunate. Cell Physiol Biochem 2014; 34:2232-2244.
37. Voelkl J, Alzoubi K, Mamar A.K., Ahmed MS, Abed M, Lang F: Stimulation of suicidal erythrocyte death by increased extracellular phosphate concentrations. Kidney Blood Press Res 2013; 38:42-51.
38. Bissinger R, Lupescu A, Zelenak C., Jilani K, Lang F: Stimulation of eryptosis by cryptotanshinone. Cell Physiol Biochem 2014; 34:432-442.
39. Lupescu A, Shaik N, Jilani K., Zelenak C, Lang E, Pasham V., Zbidah M, Plate A, Bitzer M., Foller M, Qadri SM, Lang F: Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol Biochem 2012; 30:876-888.
40. Lupescu A, Bissinger R, Herrmann T., Oswald G, Jilani K, Lang F: Induction of suicidal erythrocyte death by novobiocin. Cell Physiol Biochem 2014; 33:670-680.
41. Lupescu A, Jilani K, Zbidah M., Lang F: Patulin-induced suicidal erythrocyte death. Cell Physiol Biochem 2013; 32:291-299.
42. Bissinger R, Fischer S, Jilani K., Lang F: Stimulation of erythrocyte death by phloretin. Cell Physiol Biochem 2014; 34:2256-2265.
43. Malik A, Bissinger R, Calabro S., Faggio C, Jilani K, Lang F: Aristolochic acid induced suicidal erythrocyte death. Kidney Blood Press Res 2014; 39:408-419.
44. Jilani K, Qadri SM, Lang F: Geldanamycin-induced phosphatidylserine translocation in the erythrocyte membrane. Cell Physiol Biochem 2013; 32:1600-1609.
45. Bissinger R, Modicano P, Frauenfeld L., Lang E, Jacobi J, Faggio C., Lang F: Estramustine-induced suicidal erythrocyte death. Cell Physiol Biochem 2013; 32:1426-1436.
46. Ghashghaeinia M, Cluitmans JC, Toulany M, Saki M., Koberle M, Lang E, Dreischer P., Biedermann T, Duszenko M, Lang F., Bosman GJ, Wieder T: Age sensitivity of NFkappaB abundance and programmed cell death in erythrocytes induced by NFkappaB inhibitors. Cell Physiol Biochem 2013; 32:801-813.
47. Jacobi J, Lang E, Bissinger R., Frauenfeld L, Modicano P, Faggio C., Abed M, Lang F: Stimulation of erythrocyte cell membrane scrambling by mitotane. Cell Physiol Biochem 2014; 33:1516-1526.
48. Lupescu A, Bissinger R, Warsi J., Jilani K, Lang F: Stimulation of erythrocyte cell membrane scrambling by gedunin. Cell Physiol Biochem 2014; 33:1838-1848.
49. Qadri SM, Mahmud H, Lang E., Gu S, Bobbala D, Zelenak C., Jilani K, Siegfried A, Foller M., Lang F: Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J Cell Mol Med 2012; 16:1085-1093.
50. Lang E, Gatidis S, Freise N.F., Bock H., Kubitz R, Lauermann C, Orth H.M., Klindt C., Schuier M, Keitel V, Reich M., Liu G, Schmidt S, Xu H.C., Qadri SM, Herebian D, Pandyra AA, Mayatepek E, Gulbins E., Lang F, Haussinger D, Lang KS, Foller M, Lang PA: Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology 2015; 61:275-284.
51. Zappulla D: Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases? J Cardiometab Syndr 2008; 3:30-34.
52. Kriebardis AG, Antonelou MH, Stamoulis K.E., Economou-Petersen E, Margaritis LH, Papassideri IS: Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J Cell Mol Med 2007; 11:148-155.
53. Chung SM, Bae ON, Lim K.M., Noh JY, Lee MY, Jung YS, Chung JH: Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007; 27:414-421.
54. Borst O, Abed M, Alesutan I., Towhid ST, Qadri SM, Foller M, Gawaz M., Lang F: Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 2012; 302:C644-C651.